A protective multiple gene-deleted African swine fever virus genotype II, Georgia 2007/1, expressing a modified non-haemadsorbing CD2v protein
Open Access
- 19 October 2023
- journal article
- research article
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 12 (2) , 2265661
Abstract
African swine fever virus is a complex DNA virus that causes high fatality in pigs and wild boar and has a great socio-economic impact. An attenuated genotype II strain was constructed by replacing the gene for wildtype CD2v protein with versions in which single or double amino acid substitutions were introduced to reduce or abrogate the binding to red blood cells and reduce virus persistence in blood. The mutant CD2v proteins were expressed at similar levels to the wildtype protein on the surface of infected cells. Three recombinant viruses also had K145R, EP153R, and in one virus DP148R genes deleted. Following immunization of pigs, the virus with a single amino acid substitution in CD2v, Q96R, induced moderate levels of replication, and 100% protection against virulent ASFV. Two additional recombinant viruses had two amino acid substitutions in CD2v, Q96R, and K108D, and induced no binding to red blood cells in vitro. In immunized pigs, reduced levels of virus in blood and strong early ASFV-specific antibody and cellular responses were detected. After challenge low to moderate replication of challenge virus was observed. Reduced clinical signs post-challenge were observed in pigs immunized with the virus from which DP148R gene was deleted. Protection levels of 83-100% were maintained across a range of doses. Further experiments with virus GeorgiaΔDP148RΔK145RΔEP153R-CD2v_mutantQ96R/K108D showed low levels of virus dissemination in tissue and transient clinical signs at high doses. The results support further evaluation of GeorgiaΔDP148RΔK145RΔEP153R-CD2v_mutantQ96R/K108D as a vaccine candidate.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BBS/V0079447)
- Biotechnology and Biological Sciences Research Council (BB/X011046/1)
- Biotechnology and Biological Sciences Research Council (BB/X011038/1)
- Biotechnology and Biological Sciences Research Council (BB/CCG2250/1)
- Wellcome (207547/Z/17/Z)
- Medical Research Council (MC_UU_12010)
This publication has 30 references indexed in Scilit:
- African swine fever virus CD2v and C-type lectin gene loci mediate serological specificityJournal of General Virology, 2015
- Standardization of pathological investigations in the framework of experimental ASFV infectionsVirus Research, 2013
- Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunisationVaccine, 2011
- Genomic Analysis of Highly Virulent Georgia 2007/1 Isolate of African Swine Fever VirusEmerging Infectious Diseases, 2011
- Processing and Localization of the African Swine Fever Virus CD2v Transmembrane ProteinJournal of Virology, 2011
- In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virusJournal of General Virology, 2005
- Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-Å resolutionProceedings of the National Academy of Sciences, 1999
- Functional and Immunological Properties of the Baculovirus-Expressed Hemagglutinin of African Swine Fever VirusVirology, 1996
- Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5å resolutionStructure, 1994
- An African Swine Fever Virus Gene with Similarity to the T-Lymphocyte Surface Antigen CD2 Mediates HemadsorptionVirology, 1994